In an era where speed, relevance, and ROI define competitive advantage, the traditional corporate R&D lab has become dangerously obsolete. Too often, innovation labs devolve into “innovation theater”—well-funded, talent-rich environments that generate ideas but fail to translate them into commercial outcomes. In The R&D Lab Paradox, Sabine VanderLinden argues that the modern R&D lab must function less like an academic institution and more like a venture capitalist: operating in disciplined 90-day validation cycles, connecting discovery directly to adoption, and ultimately building a repeatable ecosystem that links R&D, commercialization, and strategic investment. The result is not experimentation for its own sake, but a scalable engine that turns emerging technologies into measurable business growth.